Erratum to miR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer
Erratum

Erratum to miR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer

Editorial Office

Annals of Translational Medicine

Correspondence to: Editorial Office. Annals of Translational Medicine. Email: editor@atmjournal.org.

Submitted Apr 19, 2022. Accepted for publication Apr 29, 2022.

doi: 10.21037/atm-2022-15


Erratum to: Ann Transl Med 2021;9:1798

In the article entitled “MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer” (1), there are some errors. Firstly, the 7th author “Hao Zheng” should be removed from the authorship and Xian-Gui Hu’s email is incorrect. The authors regret the error due to a lack of communication before publication by listing Hao Zheng in the authorship without his consent.

Therefore, the authors’ information should be corrected as follows:

The authorship, affiliation and author contribution should be corrected as

Liu Ouyang1#, Ren-Dong Liu2#, De-Qiao Lei3#, Qing-Chao Shang4#, Hui-Fen Li5, Xian-Gui Hu1, Gang Jin1

1Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China; 2Department of Hepatobiliary Surgery, General Hospital of Southern Theatre Command, Guangzhou, China; 3Department of General Surgery, General Hospital of Southern Theatre Command, Guangzhou, China; 4Department of Radiation Oncology, General Hospital of Southern Theatre Command, Guangzhou, China; 5Department of Hepatic Surgery & Interventional Radiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

#These authors contributed equally to this work.

Contributions: (I) Conception and design: G Jin; (II) Administrative support: L Ouyang, RD Liu, DQ Lei, QC Shang; (III) Provision of study materials or patients: HF Li; (IV) Collection and assembly of data: L Ouyang; (V) Data analysis and interpretation: L Ouyang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Gang Jin; Xian-Gui Hu. Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200438, China. Email: jingang@smmu.edu.cn; hxiangui@126.com/huxg88@hotmail.com.

Secondly, in the section of Methods-Real-time quantitative polymerase chain reaction (qRT-PCR), “miR-2053 expression” should be corrected to “miR-499a-5p expression”.

Thirdly, in Table 1, column 1, rows 9 “Rectum” should be corrected to “head”; column 1, rows 10 “Colon” should be corrected to “body and Tail”.

The authors confirmed the above errors did not affect either the results or the conclusions of the paper.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Ouyang L, Liu RD, Lei DQ, et al. MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer. Ann Transl Med 2021;9:1798. [Crossref] [PubMed]
Cite this article as: Editorial Office. Erratum to miR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer. Ann Transl Med 2022;10(11):651. doi: 10.21037/atm-2022-15

Download Citation